Researchers led by Indian-American scientist test vaccine they hope could cure Alzheimer's

Alzheimer's is the most common cause of dementia a continuous decline in a person's thinking, behavioural and social skills.

Published: 12th June 2019 12:40 PM  |   Last Updated: 12th June 2019 01:02 PM   |  A+A-

medicine, medical field, doctors

For representational purposes (File Photo | PTI)


WASHINGTON: A team of researchers led by an Indian-American scientist are working on a vaccine they hope could prevent Alzheimer's disease by targeting a specific protein commonly found in the brains of patients affected by the neurodegenerative disorder, according to a media report.

Alzheimer's disease is a progressive disorder that causes brain cells to degenerate and die.

Alzheimer's disease is the most common cause of dementia a continuous decline in thinking, behavioural and social skills that disrupts a person's ability to function independently.

Researchers at the University of New Mexico led by Dr Kiran Bhaskar, associate professor in the varsity's Department of Molecular Genetics & Microbiology, have started to test the vaccine on mice.

It has not yet been shown if it works in people, CBS News reported.

Bhaskar, who's been passionate about studying the disease for the last decade, says the work started with an idea in 2013.

"I would say it took about five years or so to get from where the idea generated and get the fully functioning working vaccine," he said.

"We used a group of mice that have Alzheimer's disease, and we injected them over a series of injections," said PhD student Nicole Maphis.

She said the vaccine targets a specific protein known as tau that's commonly found in the brains of Alzheimer's patients.

"These antibodies seem to have cleared (out) pathological tau.

Pathological tau is one of the components of these tangles that we find in the brains of patients with Alzheimer's disease," she explained.

The response lasted for months, according to UNM.

Those long tangles "disrupt the ability of neurons to communicate with one another," the school points out, adding that tau is "normally a stabilizing structure inside of neurons."

The mice were then given a series of maze-like tests. The mice that received the vaccine performed a lot better than those that hadn't.

However, drugs that seem to work in mice do not always have the same effect in humans.

A clinical trial involving people will be required to see if the drug helps in real life, and that's a difficult and expensive undertaking with no guarantee of success.

"We have to make sure that we have a clinical version of the vaccine so that we can test in people," Bhaskar said.

Testing just a small group would cost the UNM Health Sciences Department $2 million.

Right now, Maphis and Bhaskar are looking for partnerships to help them toward a clinical-grade vaccine.

Alzheimer's affects almost a third of senior citizens and "is on the rise, currently affecting 43 million people worldwide," the university said.

Stay up to date on all the latest World news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp